Does pregabalin (Lyrica) cause drowsiness?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 6, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Does Lyrica (Pregabalin) Cause Drowsiness?

Yes, Lyrica (pregabalin) definitively causes drowsiness (somnolence) as one of its most common adverse effects, occurring in approximately 23% of patients compared to 8% in placebo-treated patients. 1

Key Clinical Facts About Lyrica-Induced Drowsiness

Incidence and Severity

  • Somnolence affects nearly 1 in 4 patients taking Lyrica in controlled trials (23% vs 8% placebo) 1
  • This drowsiness is dose-dependent, occurring more frequently at higher doses 1
  • Somnolence typically begins shortly after initiating therapy 1
  • In patients who experience drowsiness, it persists until the last dose in 42% of cases 1

Clinical Impact

  • Drowsiness is one of the two most common reasons for drug discontinuation (4% of patients stop Lyrica due to somnolence) 1
  • The FDA label explicitly warns that Lyrica-related somnolence may impair ability to drive or operate machinery 1
  • Most adverse reactions, including drowsiness, are rated as "mild" or "moderate" intensity 1

Management Strategy

Titration approach to minimize drowsiness:

  • Start with lower initial doses (50 mg three times daily or 75 mg twice daily) 2
  • Increase gradually by 150 mg/day every 3-7 days as tolerated 2
  • Maximum dose is 600 mg/day, but slower titration reduces sedation 2

Important clinical considerations:

  • Drowsiness develops tolerance in some patients over several weeks 3
  • Combined with dizziness (30% incidence), these sedating effects require explicit patient counseling about functional impairment 1
  • Dose reduction may be necessary in patients with renal insufficiency, which can exacerbate CNS side effects 2

Common Pitfall

Do not abruptly discontinue Lyrica even if drowsiness is problematic—taper over minimum 1 week to avoid withdrawal symptoms (insomnia, nausea, headache, anxiety) 1. Instead, consider dose reduction or slower titration if restarting.

The evidence from FDA labeling 1, clinical guidelines 2, 4, and research studies 3, 5 consistently demonstrates that drowsiness is an expected, common, and dose-related adverse effect of pregabalin that requires proactive patient education and careful dose titration.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.